DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Alternative lengthening of telomeres (ALT) is likely to be an important target for anticancer treatment as approximately 10% of cancers depend on this telomere maintenance mechanism for continued growth, and inhibition of ALT can cause cellular senescence. However, no ALT inhibitors have been developed for therapeutic use because of the lack of a suitable ALT activity assay and of known ALT-specific target molecules. Here we show that partially single-stranded telomeric (CCCTAA)(n) DNA circles (C-circles) are ALT specific. We provide an assay that is rapidly and linearly responsive to ALT activity and that is suitable for screening for ALT inhibitors. We detect C-circles in blood from ALT(+) osteosarcoma patients, suggesting that the C-circle assay (CC assay) may have clinical utility for diagnosis and management of ALT(+) tumors.
Henson
Jeremy D
JD
Children's Medical Research Institute, University of Sydney, New South Wales, Australia.
Cao
Ying
Y
Huschtscha
Lily I
LI
Chang
Andy C
AC
Au
Amy Y M
AY
Pickett
Hilda A
HA
Reddel
Roger R
RR
D014408:Biomarkers, Tumor / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics*; D005819:Genetic Markers / Q000235:genetics*; D006801:Humans; D012516:Osteosarcoma / Q000175:diagnosis / Q000235:genetics*; D016615:Telomere / Q000235:genetics*
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D005819:Genetic Markers